Naloxone OTC: which statement is a requirement?

• A. Must be in manufacturer's packaging
• B. Packaging must contain the manufacturer's instructions for use
• C. Must be stored according to manufacturer's instructions
• D. Must be labeled with a non-prescription drug facts panel

Answer: (A)

Keeping naloxone in its original manufacturer packaging is the essential requirement here. When the product stays in the packaging provided by the maker, you’re guaranteed that all safety labeling, dosing directions, expiration date, and storage information stay with the product exactly as approved. This packaging also helps prevent tampering and ensures the user sees the correct, FDA-approved instructions at the moment of use, which is crucial in an overdose situation.

The other statements touch on important practices, but they’re already encompassed by having the product in the original packaging. The instructions for use, expiration and storage details are part of what the manufacturer’s packaging carries, and while labeling and storage are important, the key safeguard highlighted by this rule is maintaining the integrity and trustworthiness of the packaging itself.